Fosun Pharmaceutical Shanghai Sells 1,800 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) major shareholder Fosun Pharmaceutical Shanghai sold 1,800 shares of the company’s stock in a transaction on Tuesday, October 8th. The stock was sold at an average price of $13.13, for a total transaction of $23,634.00. Following the sale, the insider now directly owns 74,163 shares of the company’s stock, valued at approximately $973,760.19. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Fosun Pharmaceutical Shanghai also recently made the following trade(s):

• On Monday, October 14th, Fosun Pharmaceutical Shanghai sold 1,300 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.12, for a total transaction of $17,056.00.
• On Thursday, October 10th, Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.39, for a total transaction of $40,170.00.
• On Tuesday, October 1st, Fosun Pharmaceutical Shanghai sold 1,399 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.54, for a total transaction of $18,942.46.

Nature’s Sunshine Products Price Performance

Shares of NATR stock opened at $13.32 on Thursday. Nature’s Sunshine Products, Inc. has a 12 month low of $10.81 and a 12 month high of $21.72. The firm has a market capitalization of $249.48 million, a P/E ratio of 15.67 and a beta of 0.87. The company’s fifty day moving average price is $13.39 and its two-hundred day moving average price is $15.48.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its earnings results on Thursday, August 8th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). The company had revenue of $110.55 million during the quarter. Nature’s Sunshine Products had a net margin of 3.50% and a return on equity of 9.79%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Canaccord Genuity Group assumed coverage on shares of Nature’s Sunshine Products in a research report on Friday, September 13th. They set a “buy” rating and a $18.00 price target for the company. DA Davidson cut their price objective on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, August 12th. StockNews.com upgraded shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 10th. Finally, Canaccord Genuity Group assumed coverage on shares of Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 price objective on the stock.

Institutional Investors Weigh In On Nature’s Sunshine Products

Institutional investors have recently modified their holdings of the stock. Gladius Capital Management LP raised its stake in shares of Nature’s Sunshine Products by 23.9% in the 2nd quarter. Gladius Capital Management LP now owns 6,862 shares of the company’s stock valued at $103,000 after purchasing an additional 1,325 shares in the last quarter. Lazard Asset Management LLC raised its stake in shares of Nature’s Sunshine Products by 16.5% in the 1st quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock valued at $146,000 after purchasing an additional 998 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Nature’s Sunshine Products in the 2nd quarter valued at about $180,000. Bailard Inc. acquired a new stake in shares of Nature’s Sunshine Products in the 2nd quarter valued at about $197,000. Finally, SG Americas Securities LLC raised its stake in shares of Nature’s Sunshine Products by 48.7% in the 1st quarter. SG Americas Securities LLC now owns 10,716 shares of the company’s stock valued at $223,000 after purchasing an additional 3,510 shares in the last quarter. Institutional investors and hedge funds own 79.40% of the company’s stock.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.